← Back
$RPRX All transactions

Royalty Pharma plc

J

$ Value

$0

Shares

530,348

Price

$0

Filed

May 20

Insider

Name

Legorreta Pablo G.

Title

CEO, Chairman of the Board

CIK

0001507678

Roles

Director Officer

Transaction Details

Transaction Date

2025-05-16

Code

J

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

882,495

Footnotes

Represents the transfer to the Reporting Person by the RP Management Equity Incentive Plan Trust of Class A Ordinary Shares for no consideration. | Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class E ordinary shares ("Class E Shares") of Royalty Pharma Holdings Ltd ("RPH") in connection with the consummation of the transactions contemplated by the Membership Interests Purchase Agreement, dated as of January 10, 2025 (as may be amended from time to time, the "Purchase Agreement") between RPH, Royalty Pharma, LLC, RP Management, LLC, the Issuer and certain other parties thereto. | Each Class E share will vest in installments over a 5-year period. Once vested, the Class E Shares may be converted at any time into an equivalent number of Class B ordinary shares of RPH ("Class B Shares") on a one-for-one basis, and there is no expiration date for such conversion. Each Class B Share may be converted at any time into an equivalent number of Class A ordinary shares of the Issuer on a one-for-one basis, and there is no expiration date for such conversion. | Represents the Reporting Person's right to acquire certain Class E Shares held by other employees of the Issuer and its subsidiaries in the event such Class E Shares are forfeited by such employee.

Filing Info

Accession No.

0001802768-25-000063

Form Type

4

Issuer CIK

0001802768

Legorreta Pablo G.'s History

Date Ticker Type Value
2025-11-05 RPRX A $0
2025-08-08 RPRX G $0
2025-08-06 RPRX A $0
2025-06-03 PROK C $0
2025-06-03 PROK J $0
2025-06-03 PROK C $0
2025-06-03 PROK C $0
2025-05-29 PROK A $0
2025-05-16 RPRX J $0
2025-05-16 RPRX A $0

Other Insiders at RPRX (90d)

Insider Bought Sold Last
Bassler Bonnie L 2026-03-31
Coyne Terrance P.
EVP & CFO
$3.3M 2026-04-01